Merck & Co., Inc.  

(Public, NYSE:MRK)   Watch this stock  
Find more results for MRK
62.33
-0.24 (-0.38%)
Apr 28 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 62.14 - 62.65
52 week 53.06 - 66.80
Open 62.58
Vol / Avg. 9.46M/8.59M
Mkt cap 169.87B
P/E 44.44
Div/yield 0.47/3.02
EPS 1.40
Shares 2.74B
Beta 0.84
Inst. own 76%
Jul 28, 2017
Q2 2017 Merck & Co Inc Earnings Release - 9:30AM EDT - Add to calendar
Jul 28, 2017
Q2 2017 Merck & Co Inc Earnings Call - 8:00AM EDT - Add to calendar
May 23, 2017
Merck & Co Inc Annual Shareholders Meeting - 9:00AM EDT - Add to calendar
May 4, 2017
Merck & Co Inc at Deutsche Bank Health Care Conference - 8:40AM EDT - Add to calendar
May 2, 2017
Q1 2017 Merck & Co Inc Earnings Release - 9:30AM EDT - Add to calendar
May 2, 2017
Q1 2017 Merck & Co Inc Earnings Call - 8:00AM EDT - Add to calendar
Mar 27, 2017
Merck & Co Inc at Sachs Associates Neuroscience BioPartnering & Investment Forum
Mar 2, 2017
Merck & Co Inc at Deutsche Bank Pharma One-on-One Day
Feb 15, 2017
Merck & Co Inc at Leerink Partners Global Healthcare Conference
Feb 2, 2017
Q4 2016 Merck & Co Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin -5.80% 9.90%
Operating margin -7.16% 11.94%
EBITD margin - 59.36%
Return on average assets -2.43% 4.00%
Return on average equity -5.69% 9.25%
Employees 68,000 -
CDP Score - B

Address

2000 Galloping Hill Rd
KENILWORTH, NJ 07033-1310
United States - Map
+1-908-7404000 (Phone)
+1-908-4231987 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through four segments: Pharmaceutical, Animal Health, Healthcare Services and Alliances. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed healthcare providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices.

Officers and directors

Kenneth C. Frazier Chairman of the Board, President, Chief Executive Officer
Age: 62
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Robert M. Davis Chief Financial Officer, Executive Vice President
Age: 50
Bio & Compensation  - Reuters
Michael J. Holston Executive Vice President, General Counsel
Age: 54
Bio & Compensation  - Reuters
Mirian M. Graddick-Weir Executive Vice President - Human Resources
Age: 62
Bio & Compensation  - Reuters
Sanat Chattopadhyay Executive Vice President and President - Merck Manufacturing Division
Age: 57
Bio & Compensation  - Reuters
Richard R. DeLuca Jr. Executive Vice President, President - Merck Animal Health
Age: 54
Bio & Compensation  - Reuters
Julie Louise Gerberding M.D. Executive Vice President and Chief Patient Officer, Strategic Communications, Global Public Policy and Population Health
Age: 61
Bio & Compensation  - Reuters
Roger M. Perlmutter M.D. Ph.D. Executive Vice President, President - Merck Research Laboratories
Age: 65
Bio & Compensation  - Reuters
Adam H. Schechter Executive Vice President, President - Global Human Health
Age: 52
Bio & Compensation  - Reuters
Rita A. Karachun Senior Vice President Finance - Global Controller
Age: 53
Bio & Compensation  - Reuters